Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
With
Aventis Pharmaceuticals
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Patients who have undergone a radical prostatectomy (should have unmeasurable PSA) or radiation therapy for prostate cancer and who have high risk disease as defined by one of the following:
* AST, ALT and Alkaline Phosphatase must be within the range allowing for eligibility.
* Signed patient informed consent.
* Men of childbearing potential must be willing to consent to using effective contraception while on treatment and for three months thereafter.
You may not be if
Peripheral neuropathy \> grade 1
History of severe hypersensitivity to Taxotere® or other drugs formulated with polysorbate 80.
Patients who have received previous chemotherapy or are being treated on another clinical trial using an investigational agent.
Active infection within 14 days of beginning treatment
Patients with a serious illness or medical condition, history of significant neurologic or psychiatric or active infection.
Patients with a current malignancy. Patients with prior a history of in situ lobular carcinoma of the breast, basal or squamous cell skin cancer, are eligible.
Clareo Health | Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation
